Reactivation of occult hepatitis B virus infection under treatment with abatacept: a case report

BACKGROUND: Abatacept (ABA) is a fusion receptor protein containing the CTLA-4 domain that prevents the activation of naïve T cells by binding the CD80 and CD86 molecules expressed on the surface of dendritic cells, indicated for the treatment of moderate to severe rheumatoid arthritis (RA). There i...

Descripción completa

Detalles Bibliográficos
Autores principales: Talotta, Rossella, Atzeni, Fabiola, Sarzi Puttini, Piercarlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839135/
https://www.ncbi.nlm.nih.gov/pubmed/27098382
http://dx.doi.org/10.1186/s40360-016-0060-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839135/
https://www.ncbi.nlm.nih.gov/pubmed/27098382
http://dx.doi.org/10.1186/s40360-016-0060-2

Ejemplares similares